Drugs Made In America Acquisition DMIIU
NASDAQ DMIIU
$10.23 +0.00 (+0.00%)
At close: Nov 4, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMIIU) Preferred Stock Liabilities (2025 - 2026)

Updated

Drugs Made In America Acquisition's Preferred Stock Liabilities was $513.88 million in Q2 2026.

Analysis

Drugs Made In America Acquisition (DMIIU) Preferred Stock Liabilities (2025 - 2026) Analysis & Trends

At the end of FY2025, Preferred Stock Liabilities at Drugs Made In America Acquisition came in at $504.93 million.

Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 513.88 Mn
Dec 31, 2025 504.93 Mn
Sep 30, 2025 500.11 Mn
API Access

Drugs Made In America Acquisition Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=DMIIU&period=max&api_key=YOUR_API_KEY